Home › Occupations › Bioengineers and Biomedical Engineers › Marlborough, MA
Bioengineers and Biomedical Engineers in Marlborough, MA: H-1B salaries
23 labor condition applications for this occupation with a work site in Marlborough, MA. Median offered base salary $115,000; middle half $99,830–$125,599.
By wage level
| Wage level | Median salary |
|---|---|
| Level I (entry) | $95,432 |
| Level II (qualified) | $96,616 |
| Level III (experienced) | $107,931 |
| Level IV (fully competent) | $136,552 |
The Department of Labor sets four prevailing wage levels for each occupation and area, from Level I (entry) to Level IV (fully competent). The employer picks the level that matches the job's requirements.
Employers
| Employer | LCAs | Median salary |
|---|---|---|
| Boston Scientific Corporation | 11 | $107,931 |
| Candela Corporation | 2 | $130,000 |
| Global Life Sciences Solutions USA LLC | 2 | $132,430 |
| Sumitomo Pharma Oncology, Inc. | 1 | $166,036 |
| CardioFocus, Inc. | 1 | $115,000 |
| ModernaTX, Inc. | 1 | $93,538 |
| Sartorius Stedim North America | 1 | $124,800 |
| Akoya Biosciences, Inc. | 1 | $84,918 |
| IPG Medical Corporation | 1 | $145,000 |
| Hologic, Inc. | 1 | $126,198 |
| The Ohio State University | 1 | $86,382 |
Job titles
- Sr. Specialist, Regulatory Affairs2
- Associate Director, Pharmacovigilance Systems1
- Sr. Medical Affairs Specialist1
- Quality Engineer II1
- Sr. Systems Engineer1
- Principal Rhythmia Mapping Specialist1
- Senior Quality Engineer1
- Senior Systems Engineer1
- Design Quality Engineer1
- Senior Quality Assurance Engineer1
- Specialist, Quality Assurance1
- Sr. Quality Supervisor1
- Field Service Engineer1
- Scientist, Bioengineering1
- Research Associate II1
H-1B sponsors in Marlborough, MA →
Salaries are the lower end of the wage offered on each application, converted to a yearly amount; statistics use certified full-time applications only. An LCA is not a visa approval and one LCA can cover several positions. Source: U.S. Department of Labor, OFLC LCA Disclosure Data, fiscal years 2023–2026 (latest decision Jun 30, 2026).